Format
Items per page
Sort by

Send to:

Choose Destination

Results: 8

Cited In for PubMed (Select 15457680)

1.

Reverse transcriptase backbone can alter the polymerization and RNase activities of non-nucleoside reverse transcriptase mutants K101E+G190S.

Wang J, Li D, Bambara RA, Dykes C.

J Gen Virol. 2013 Oct;94(Pt 10):2297-308. doi: 10.1099/vir.0.054999-0. Epub 2013 Jun 26.

2.

Outcomes following virological failure and predictors of switching to second-line antiretroviral therapy in a South African treatment program.

Johnston V, Fielding KL, Charalambous S, Churchyard G, Phillips A, Grant AD.

J Acquir Immune Defic Syndr. 2012 Nov 1;61(3):370-80. doi: 10.1097/QAI.0b013e318266ee3f.

3.

Protease Inhibitor Resistance Is Uncommon in HIV-1 Subtype C Infected Patients on Failing Second-Line Lopinavir/r-Containing Antiretroviral Therapy in South Africa.

Wallis CL, Mellors JW, Venter WD, Sanne I, Stevens W.

AIDS Res Treat. 2011;2011:769627. doi: 10.1155/2011/769627. Epub 2010 Dec 2.

4.

Replicative fitness costs of nonnucleoside reverse transcriptase inhibitor drug resistance mutations on HIV subtype C.

Armstrong KL, Lee TH, Essex M.

Antimicrob Agents Chemother. 2011 May;55(5):2146-53. doi: 10.1128/AAC.01505-10. Epub 2011 Mar 14.

5.

Adult combination antiretroviral therapy in sub-Saharan Africa: lessons from Botswana and future challenges.

Wester CW, Bussmann H, Koethe J, Moffat C, Vermund S, Essex M, Marlink RG.

HIV Ther. 2009 Sep 1;3(5):501-526.

6.

Five-year follow up of genotypic resistance patterns in HIV-1 subtype C infected patients in Botswana after failure of thymidine analogue-based regimens.

Doualla-Bell F, Gaolathe T, Avalos A, Cloutier S, Ndwapi N, Holcroft C, Moffat H, Dickinson D, Essex M, Wainberg MA, Mine M.

J Int AIDS Soc. 2009 Oct 25;12:25. doi: 10.1186/1758-2652-12-25.

7.

High prevalence of the K65R mutation in human immunodeficiency virus type 1 subtype C isolates from infected patients in Botswana treated with didanosine-based regimens.

Doualla-Bell F, Avalos A, Brenner B, Gaolathe T, Mine M, Gaseitsiwe S, Oliveira M, Moisi D, Ndwapi N, Moffat H, Essex M, Wainberg MA.

Antimicrob Agents Chemother. 2006 Dec;50(12):4182-5. Epub 2006 Oct 2.

8.

Impact of human immunodeficiency virus type 1 subtype C on drug resistance mutations in patients from Botswana failing a nelfinavir-containing regimen.

Doualla-Bell F, Avalos A, Gaolathe T, Mine M, Gaseitsiwe S, Ndwapi N, Novitsky VA, Brenner B, Oliveira M, Moisi D, Moffat H, Thior I, Essex M, Wainberg MA.

Antimicrob Agents Chemother. 2006 Jun;50(6):2210-3.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk